$CBZ

CBIZ soars 78% in 4 months after InvestingPro Fair Value signal

CBIZ, Inc. (NYSE:CBZ) rose 78.46% in four months after InvestingPro's Fair Value analysis identified it as undervalued. The stock traded at $30.50 on April 30, 2026, with a target of $48.98, reaching $54.43 by August 10. The company operates in the Industrials sector, providing business services. Grant Thornton later announced a $5 billion acquisition, validating the undervaluation thesis. InvestingPro's methodology combines multiple valuation approaches to estimate intrinsic value.

Original reporting
Published Aug 29, 2026, 11:26 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 30, 2026, 3:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$CBZ
Bullish
high confidence
Mentioned
$CBZ
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CBZBullishHigh
01

Why it matters

The $5 billion cash offer represents a 60% premium to fair‑value estimates, confirming the stock's undervaluation narrative.

02

Market read

The acquisition is a catalyst for CBIZ's price action and signals broader consolidation trends.

03

What to watch

Potential financing constraints for Grant Thornton and cultural integration challenges.

Relevance 9/10Novelty 9/10Timing: post‑announcement July 2026 acquisition news

Background

CBIZ is a NYSE‑listed provider of accounting, tax, advisory, and consulting services.

Company-level read

Ticker impact

$CBZBullishHigh confidence
Context

Grant Thornton announced a $5 billion cash acquisition of CBIZ, driving a 78% price surge.

Expected impact

Expect continued upside as the deal closes, potentially adding 5‑10% on the post‑announcement rally.

Evidence & confidence

A large cash deal at a 60% fair‑value premium validates the recent price move and suggests limited downside.

Market effects

Consolidation in professional services may pressure peers like RSM and Deloitte affiliates.

U.S. industrials sector gains from the high‑profile deal.

Highlights continued M&A activity in the post‑AI boom environment.

Counterpoint

Deal could face regulatory scrutiny or integration risk, limiting upside.

Key entities

  • Grant Thornton

    Global professional services firm offering cash acquisition.

  • CBIZ

    Provider of business services with $2.77 B revenue.

Related articles

$CBZMed

CBIZ, Inc. (CBZ): Results of Operations and Financial Condition

CBIZ, Inc. (CBZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Item 2.02. Results of Operations and Financial Condition The information set forth in Item 7.01 below is incorporated herein by reference. Item 7.01. Regulation FD Disclosure On October 19, 2026, CBIZ, Inc. (“CBIZ”, the “Company”, “we”, “our” or “us”) furnished a Current Report o

$CBZMedAI 8/10

CBIZ Earnings Up In Q3

CBIZ reported Q3 net income of $47.24M, up from $30.15M last year, with EPS at $0.79. Adjusted net income rose to $72.20M, and revenue increased to $702.24M. The company plans a $5B acquisition by Grant Thornton, expected to close in Q4 2026 at $55 per share, making it private. CBIZ closed at $54.78 on Friday.

$CBZHighAI 8/10

CBIZ Q3 Revenue Reaches $702 Million as Net Income Rises 57%

CBIZ reported Q3 2026 revenue of $702.2M, up 1.2% YoY, with net income rising 56.7% to $47.2M. The company announced a proposed acquisition by Grant Thornton for $5.0B, or $55.00 per share, expected to close in Q4 2026. Nine-month revenue totaled $2.23B, with net income of $218.6M. CBIZ will not provide full-year guidance due to the pending transaction.